Ghana Stock Exchange · DASPHARMA

DASP

Dannex Ayrton Starwin Plc (DASPHARMA) Share Price Today

Comparable Ghana cedis figures for Dannex Ayrton Starwin Plc are not in this set yet.

Updated on , the date of the newest filing.

No comparable cedis figures have been extracted from Dannex Ayrton Starwin Plc's filings yet.

Latest available

Latest available is the newest checked figure. Current means that period ended within about 12 months. Older filing means the last figure we have is older than that.

These latest available figures are not from the same period. Read the period beside each one.

Profit after tax

Not availableNot available

No checked figure in full Ghana cedis.

Total assets

Not availableNot available

No checked figure in full Ghana cedis.

Price, change and volume

Change 0.00 (0.00%). Volume 0 shares.

Last saved price as of 2 November 2026 at 13:59 UTC, from the market feed this site stores. It can be delayed. It is not a forecast.

See DASPHARMA on the market page. The exchange’s own prices are on Ghana Stock Exchange trading and data, as of 2 November 2026 at 13:59 UTC for the figure saved here.

Chart

A price history is not in the saved feed. The feed stores one price, so this page does not draw a price chart. The filing chart further down, when the filings support one, is profit or another filing figure. It is not the share price.

No filing chart is available for this issuer either.

About Dannex Ayrton Starwin Plc

What does this company do?

Dannex Ayrton Starwin Plc (DASPHARMA) is listed on the Ghana Stock Exchange. On this site its sector is Consumer goods. Consumer-goods companies on the Ghana Stock Exchange typically sell products people buy for the household. This page does not describe Dannex Ayrton Starwin Plc's own products.

How does it make money?

Checked profit and asset figures in full Ghana cedis are not in this set, so this page does not describe how Dannex Ayrton Starwin Plc earns money beyond its sector.

Dividends

Dividend per share is not in the saved price feed, so this page does not print one. A declaration history, with record dates and payment dates, is not in the saved data either.

A dividend yield for DASPHARMA is not in the saved market-report table.

Dividends on the Ghana Stock Exchange explains the dates and the September 2026 yields. What is a dividend? explains the word. A yield is not a reason to buy.

What the numbers mean

Kofi's glossary, not a verdict. Price-to-earnings needs earnings per share. Earnings per share is not in the saved price feed, so this page does not calculate a P/E.

A yield is not in the saved report for this symbol, so this page does not calculate one.

Profit after tax and total assets, further down, come from filings. Each one keeps its Latest available period. A bigger profit is not a reason to buy the shares.

How to buy DASPHARMA shares

Through a licensed broker. The steps are in How to buy shares on the Ghana Stock Exchange. When investing on Yanci launches, orders will go through Teak Tree Brokerage. Check that firm on the Ghana Stock Exchange and SEC lists. This page does not tell you to buy, sell or hold Dannex Ayrton Starwin Plc.

Facts from the filings

Key facts

Exchange
Ghana Stock Exchange
Ticker
DASPHARMA
Industry in the market snapshot
Pharmaceuticals & Biotechnology
Last saved share price
GH₵0.93
Shares in the market snapshot
84,765,898
How the figures move

How the figures move

Not enough comparable periods for a chart yet. The table lists what there is.

No comparable cedis figures yet. The filings are listed below. A missing number usually means the unit or the currency was not clear enough to convert.

Earnings per share

Earnings per share

As printed in the filings, with pesewas shown in cedis. Banks often annualise interim results, so a quarter or half year can look larger than the full year.

PeriodAs printed
Full year ended 31 December 2025₵0.1729 per share, as printed
Full year ended 31 December 2024₵11 per share, as printed
Full year ended 31 December 2023₵0.0891 per share, as printed
Full year ended 31 December 2021₵0.0576 per share, as printed
Filings

Filings on the Ghana Stock Exchange

Each link opens the original PDF on the exchange's website.

  • PR-327 DANNEX AYRTON STARWIN PLC UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 JUNE 2026

    Half year ended 30 June 2026 · Unaudited · Published 31 July 2026

  • PR-198 DANNEX AYRTON STARWIN PLC UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2026

    First quarter ended 31 March 2026 · Unaudited · Published 4 May 2026

  • PR-197 DANNEX AYRTON STARWIN PLC ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

    Full year ended 31 December 2025 · Published 4 May 2026

  • PR-025 DANNEX AYRTON STARWIN PLC UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2025

    Full year ended 31 December 2025 · Unaudited · Published 30 January 2026

  • PR-422 DANNEX AYRTON STARWIN PLC UNAUDITED FINANCIAL STATEMENTS FOR FOR THE PERIOD ENDED SEPTEMBER 30 2025

    Third quarter ended 30 September 2025 · Unaudited · Published 4 November 2025

  • PR-364 DANNEX AYRTON STARWIN PLC ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2024.

    Full year ended 31 December 2024 · Published 18 September 2025

Show 17 earlier filings
  • PR-299 DANNEX AYRTON STARWIN PLC UNAUDITED STATEMENTS OF COMPREHENSIVE INCOME FOR THE PERIOD ENDED JUNE 30, 2025

    Half year ended 30 June 2025 · Unaudited · Published 31 July 2025

  • PR-158 DANNEX AYRTON STARWIN PLC UNAUDITED FINANCIAL STATEMENTS FOR THE QUARTER ENDED MARCH 31, 2025

    Quarter ended 31 March 2025 · Unaudited · Published 2 May 2025

  • PR-157 DANNEX AYRTON STARWIN PLC ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2024

    Full year ended 31 December 2024 · Published 2 May 2025

  • PR-031 DANNEX AYRTON STARWIN PLC UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2024

    Full year ended 31 December 2024 · Unaudited · Published 3 February 2025

  • PR-067 DANNEX AYRTON STARWIN PLC ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2023

    Full year ended 31 December 2023 · Published 2 April 2024

  • PR-274 DANNEX AYRTON STARWIN PLC UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30TH JUNE 2023

    Half year ended 30 June 2023 · Unaudited · Published 26 July 2023

  • PR-133 DANNEX AYRTON STARWIN PLC UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD ENDED MARCH 31, 2023

    First quarter ended 31 March 2023 · Unaudited · Published 28 April 2023

  • PR-116 DANNEX AYRTON STARWIN PLC ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2022

    Full year ended 31 December 2022 · Published 25 April 2023

  • PR. 034/2023 DASPHARMA UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD ENDED DECEMBER 31, 2022

    Full year ended 31 December 2022 · Unaudited · Published 1 February 2023

  • PR. 358/2022 DASPHARMA UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD ENDED SEPTEMBER 30, 2022

    Third quarter ended 30 September 2022 · Unaudited · Published 31 October 2022

  • PR. 234/2022 DASPHARMA UNAUDITED FINANCIAL STATEMENTS AS AT JUNE 30,2022

    Half year ended 30 June 2022 · Unaudited · Published 26 July 2022

  • PR. 113/2022 DASPHARMA UNAUDITED FINANCIAL STATEMENTS AS AT MARCH 31,2022

    First quarter ended 31 March 2022 · Unaudited · Published 25 April 2022

  • PR. 099/2022 DANNEX AYRTON STARWIN PLC (DASPHARMA ANNUAL REPORT AND FINANCIAL STATEMENTS AS AT DECEMBER 31,2021

    Full year ended 31 December 2021 · Published 5 April 2022

  • PR. 027/2022 DASPHARMA UNAUDITED FINANCIAL STATEMENTS AS AT DECEMBER 31,2021

    Full year ended 31 December 2021 · Unaudited · Published 1 February 2022

  • PR. 393/2021 DASPHARMA UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2021

    Third quarter ended 30 September 2021 · Unaudited · Published 26 October 2021

  • PR. 161/2021 DASPHARMA UNAUDITED FINANCIAL STATEMENTS FOR THE FIRST QUARTER ENDING 31 MARCH 2021

    First quarter ended 31 March 2021 · Unaudited · Published 1 May 2021

  • PR. 023/2021 DASPHARMA UNAUDITED FINANCIAL STATEMENTS FOR THEYEAR ENDED 31 DECEMBER 2020

    Full year ended 31 December 2020 · Unaudited · Published 4 February 2021

Kofi on reading these figures
Related companies

Frequently asked questions

What does Dannex Ayrton Starwin Plc do?

Dannex Ayrton Starwin Plc (DASPHARMA) is listed on the Ghana Stock Exchange. On this site its sector is Consumer goods. Consumer-goods companies on the Ghana Stock Exchange typically sell products people buy for the household. This page does not describe Dannex Ayrton Starwin Plc's own products.

How does Dannex Ayrton Starwin Plc make money?

Checked profit and asset figures in full Ghana cedis are not in this set, so this page does not describe how Dannex Ayrton Starwin Plc earns money beyond its sector.

What is the DASPHARMA share price?

The latest price we have for DASPHARMA is GH₵0.93 as of 2 November 2026 at 13:59 UTC. It can be delayed. It is not a forecast and not a recommendation.

How much is one DASPHARMA share?

The latest price we have for DASPHARMA is GH₵0.93 as of 2 November 2026 at 13:59 UTC. It can be delayed. It is not a forecast and not a recommendation.

Does Dannex Ayrton Starwin Plc pay dividends?

The saved price feed does not include a dividend per share for DASPHARMA, and a dividend yield for this symbol is not in the saved market-report table. Whether Dannex Ayrton Starwin Plc pays a dividend is decided by the company. Check its announcement.

How do I buy DASPHARMA shares?

Through a licensed broker on the Ghana Stock Exchange. The steps are in How to buy shares on the Ghana Stock Exchange. This page does not tell you to buy DASPHARMA.

Does Yanci recommend DASPHARMA?

No. This page explains Dannex Ayrton Starwin Plc using Ghana Stock Exchange filings and a saved share price. It is not a recommendation to buy, sell or hold any security.

Kofi teaches. Kofi never tells you what to buy or sell. This is education, not financial advice. Rates and prices change, so check with a licensed broker, bank, or fund manager.

Source: Ghana Stock Exchange filings, read automatically, so a number, unit or date can be misread. Figures that failed a check, or could not be put in full cedis, are left out. This page is for learning. It is not investment advice or an offer to buy or sell any security.

Kofi will walk you through companies like these in the app.

Join the waitlist for early access.

Join the Waitlist